Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Faris, Madanat"'
Autor:
Mayada Abu Shanap, Haytham Al Jabour, Rawad Rihani, Hasan Hashem, Amal Abu Ghosh, Abdelghani Tbakhi, Nazmi Kamal, Iyad Sultan, Faris Madanat
Publikováno v:
Cancer Reports, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction T‐cell acute lymphoblastic leukemia (T‐ALL) accounts for approximately 15% of all newly diagnosed ALL in children and adolescents and is associated with worse outcomes compared to pre‐B ALL. We aimed to decrease T‐ALL re
Externí odkaz:
https://doaj.org/article/e85ed67c2c624474b41112d8393906bb
Autor:
Mayada Abu Shanap, Haytham Al Jabour, Rawad Rihani, Hasan Hashem, Amal Abu Ghosh, Abdelghani Tbakhi, Nazmi Kamal, Iyad Sultan, Faris Madanat
Publikováno v:
Cancer Reports. 6
Autor:
Mayada Abu Shanap, Haytham Aljbour, Rawad Rihani, Hasan Hashem, Amal Abu Ghosh, Abdelghani Tbakhi, Nazmi Kamal, Iyad Sultan, Faris Madanat
Introduction: T-cell acute lymphoblastic leukemia (T-ALL) accounts for approximately 15% of all newly diagnosed ALL in children and adolescents and is associated with worse outcomes compared to pre-B ALL. We aimed to decrease T-ALL relapses by intens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cc3aecf9a61607ea63d60052cf30c73
https://doi.org/10.22541/au.163257193.36023182/v1
https://doi.org/10.22541/au.163257193.36023182/v1
Autor:
Zead Ismael I.K. Matti, Jaafar M.H. Abdulkadhim, Tariq Abadi Al-Shujairi, Rawad Rihani, Toshi Inoshita, Le T.N. Uyen, Faris Madanat, Kenichi Koike, Salma Abbas Al-Hadad, Lika’a Fasih Y. Al-Kzayer, Hasanein H. Ghali, Maher A. Sughayer, Mazin Faisal Al-Jadiry, Minoru Kamata, Tingting Liu, Kazuyuki Matsuda, Kazuo Sakashita
Publikováno v:
Pediatric Blood & Cancer. 62:2157-2161
Background KRAS and NRAS gene mutations are frequently observed in childhood leukemia. The objective of this study was to determine the frequency of RAS mutations and the association between RAS mutations and other genetic aberrations in Arab Asian c
Autor:
Khaldoun Alkayed, Ismaeel Azayyat, Hiba Jaber, Faris Madanat, Nazmi Kamal, Fareed Barakat, Rawad Rihani
Publikováno v:
Hematology/Oncology and Stem Cell Therapy. 9:126-128
Autor:
Salam Abu Jmaian, Fareed Barakat, Ismael Zayyat, Tahani Hani Sarrawi, Maha Rezeq, Faris Madanat
Publikováno v:
Hematology/oncology and stem cell therapy. 11(1)
Autor:
Kazuyuki Matsuda, Tingting Liu, Lika’a Fasih Y. Al-Kzayer, Jaafar M.H. Abdulkadhim, Hussam M. Salih Al-Abdullah, Kenichi Koike, Janan Ghalib Hasan, Le T.N. Uyen, Zead Ismael I.K. Matti, Tariq Abadi Al-Shujairi, Kazuo Sakashita, Salma Abbas Al-Hadad, Toshi Inoshita, Faris Madanat, Minoru Kamata, Maher A. Sughayer, Mazin Faisal Al-Jadiry
Publikováno v:
Pediatric Blood & Cancer. 61:1980-1985
Background. RUNX1 mutation plays an important role in adult leukemic transformation. However, its contribution to the development of childhood leukemia remains unclear. In the present study, we analyzed point mutations of RUNX1 gene in children and a
Autor:
Zakiya Al-Lamki, Scott C. Howard, Abdullah A Al-Nasser, Sihem Barsaoui, Robert J. Arceci, Hussein Al-Mukharraq, Yaddanapudi Ravindranath, Eyad Torfa, Gamal Zain, Andreas E. Kulozik, Faris Madanat, Mohammad Farranoush, Naima Al-Mulla, Gregory H. Reaman, M. Khattab, Parvaneh Vossough, Murat Tuncer, Samar Muwakkit, Prem Chandra, Abdulrahman Mohd AlJassmi, Salah Mahmoud
Publikováno v:
Pediatric Blood & Cancer. 61:1403-1410
Background Little is known about childhood ALL in the Middle East. This study was undertaken by MECCA as initial efforts in collaborative data collection to provide clinical and demographic information on children with ALL in the Middle East. Procedu
Autor:
Ayad Ahmed Hussein, Hadeel Halalsheh, Khaldoun Alkayed, Faris Madanat, Khadra Salami, Maha Riziq
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 6, Iss 1, Pp 34-41 (2013)
Background: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) remained until recently the molecular genetic abnormality associated with the worst outcome. Hematopoietic stem cell transplant (HSCT) was considered the treatment of
Publikováno v:
Pediatric Blood & Cancer. 57:385-391
Background Accurate data about childhood acute lymphoblastic leukemia (ALL) in low- and middle-income countries are lacking. Our study is designed to assess survival of childhood ALL at King Hussein Cancer Center (KHCC) using modified St. Jude Childr